Skip to main content

Table 1 Antibodies, company, clone, pre-treatment and dilution of used antibodies.

From: Cytokeratin 8/18 expression indicates a poor prognosis in squamous cell carcinomas of the oral cavity

Antibody Company Clone Pre-treatment Dilution
Ck 5/6 DAKO, Glostrup, Denmark D5/16B4 Autoclave 10 min 1 : 80
Ck 8/18 Dianova, Hamburg, Germany K8.8/DC10 Autoclave 10 min, citrate buffer 1 : 40
Ck 1 Novocastra, Newcastle, UK 34βB4 Steamer 30 min, citrate buffer 1 : 150
Ck 10 DAKO, Glostrup, Denmark DE-K10 Steamer 30 min, citrate buffer 1 : 400
Ck 14 Dianova Hamburg, Germany LL002 Steamer 30 min, citrate buffer 1 : 50
Ck 19 Quartett GmbH, Berlin, Germany KS19.1 Steamer 30 min, citrate buffer 1 : 80
Vimentin Ventana Inc., Tucson, USA V9 Steamer 30 min, citrate buffer 1 : 1000
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us